VTMB — Vitamin Blue Share Price
- $0.00m
- $0.31m
- $0.13m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | n/a | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 0.01 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | n/a | ||
Return on Equity | n/a | ||
Operating Margin | -571.75% |
Financial Summary
Year End 31st Dec | Unit | 2008 | 2009 | 2010 | 2011 | 2012 | 2013E | 2014E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | $m | n/a | 0.13 | 0.11 | 0.1 | 0.13 | n/a | n/a | -0.55% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Vitamin Blue, Inc., is a water board sports company. The Company designs, manufactures and distributes water board sports wear and water board sports accessories. It specializes in boardshorts, surfboard bags, SUP Bags, prone board bags, windsurf bags and roof rack pads. It offers men's boardshorts and printed men's tees. The Company makes custom board bags for surf, SUP, prone paddleboards and more. It also offers stock board bag sizes for longboard bags, fish surfboard bags and SUP bags. It provides non logo roof rack pads in a variety of lengths (18 inches, 27 inches, 36 inches and 54 inches), styles (Aero, Regular, AeroBlade and Truck) and colors. Its roof rack crossbar pads are made for car roof rack pads, SUV rack pads, van rack pads and truck racks. It also offers easy to use tie down straps. It manufactures most of its water board sports wear and accessories in-house. The Company manufactures all of its products at its facility in Costa Mesa, California.
Directors
- Last Annual
- December 31st, 2012
- Last Interim
- September 30th, 2013
- Incorporated
- May 25th, 1999
- Public Since
- September 6th, 2012
- No. of Shareholders
- 290
- No. of Employees
- 1
- Sector
- Leisure Products
- Industry
- Consumer Cyclicals
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 1,653,405,000

- Address
- 1005 W 18th St, COSTA MESA, 92627
- Web
- https://www.vitaminblue.com/
- Phone
- +1 9496454591
- Auditors
- HJ Associates & Consultants, LLP
Similar to VTMB
Altitude International Holdings
Pink Sheets on Nasdaq
Bollinger Industries
Pink Sheets on Nasdaq
Brownie's Marine
Pink Sheets on Nasdaq
Exeo Entertainment
Pink Sheets on Nasdaq
Jupiter Marine International Holdings
Pink Sheets on Nasdaq
FAQ
As of Today at 24:00 UTC, shares in Vitamin Blue are trading at $0.00. This share price information is delayed by 15 minutes.
Shares in Vitamin Blue last closed at $0.00 and the price had moved by over the past 365 days. In terms of relative price strength the Vitamin Blue share price has underperformed the S&P500 Index by -6.57% over the past year.
There is no consensus recommendation for this security.
Find out moreVitamin Blue does not currently pay a dividend.
Vitamin Blue does not currently pay a dividend.
Vitamin Blue does not currently pay a dividend.
To buy shares in Vitamin Blue you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $0.00, shares in Vitamin Blue had a market capitalisation of $0.00m.
Here are the trading details for Vitamin Blue:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: VTMB
Based on an overall assessment of its quality, value and momentum Vitamin Blue is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Vitamin Blue. Over the past six months, its share price has underperformed the S&P500 Index by -65.5%.
As of the last closing price of $0.00, shares in Vitamin Blue were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Vitamin Blue PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $0.00.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Vitamin Blue's management team is headed by:
- Frank Ornelas - CEO
- Veronica Ornelas - VPR